Proceedings from the 4th NextGen Therapies for SJIA and MAS virtual symposium held February 13–14, 2022
Main Authors: | Rashmi Sinha, Fabrizio De Benedetti, Alexei A. Grom, on behalf of the participants listed below |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | Pediatric Rheumatology Online Journal |
Online Access: | https://doi.org/10.1186/s12969-023-00863-2 |
Similar Items
-
The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIA
by: Grant Schulert, et al.
Published: (2024-01-01) -
The 4th NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design study
by: Fabrizio de Benedetti, et al.
Published: (2024-01-01) -
The 4th NextGen therapies of SJIA and MAS, part 4: it is time for IL-18 based trials in systemic juvenile idiopathic arthritis?
by: Scott W. Canna, et al.
Published: (2024-01-01) -
The 4th NextGen Therapies for SJIA and MAS: part 1 the elephant in the room: diagnostic/classification criteria for systemic juvenile idiopathic arthritis and adult-onset still’s disease
by: Peter A. Nigrovic, et al.
Published: (2024-01-01) -
NextGen learning mobile application
by: Tan, Sarah Si Jia
Published: (2019)